EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Interferon-Induced Transmembrane Protein 1 (IFITM1) Is Downregulated in Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumors

Gun-Hoo Park iD, Eunkuk Park iD, Su-Jin Lee, Kyubin Lim, Jeonghyun Kim, Jun Eun Park, Seon-Yong Jeong iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25179265 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Gun-Hoo Park und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Genetics, Ajou University School of Medicine, Suwon 16499, Republic of Korea. Hauptthemen laut MEDLINE: Neurofibromatosis 1, Nerve Sheath Neoplasms, Antigens, Differentiation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Health & Welfare, Republic of Korea, Korea University, Ministry of Health & Welfare, Republic of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neurofibromatosis type 1 (NF1), an autosomal dominant genetic disorder, is caused by mutations in the NF1 gene, which encodes the GTPase-activating protein neurofibromin. The pathogenesis of the tumor progression of benign plexiform neurofibromas (PNs) and malignant peripheral nerve sheath tumors (MPNSTs) remain unclear. Here, we found that interferon-induced transmembrane protein 1 (IFITM1) was downregulated in MPNST tissues compared to those in PN tissues from patients with NF1. Overexpression of IFITM1 in NF1-associated MPNST cells resulted in a significant decrease in Ras activation (GTP-Ras) and downstream extracellular regulatory kinase 1/2 (ERK1/2) phosphorylation, whereas downregulation of IFITM1 via treatment with small interfering RNA in normal Schwann cells had the opposite result, indicating that expression levels of IFITM1 are closely associated with tumor progression in NF1. Treatment of MPNST cells with interferon-gamma (IFN-γ) significantly augmented the expression of IFITM1, thereby leading to a decrease in Ras and ERK1/2 activation. Despite the small number of patient samples, these findings may potentially provide a new target for chemotherapy in patients with NF1-associated MPNSTs. In xenograft mice injected with MPNST cells, IFN-γ treatment successfully suppressed tumor progression with increased IFITM1 expression and decreased Ras and ERK1/2 activation in tumor tissues. Collectively, these results suggest that IFITM1 is closely involved in MPNST pathogenesis and that IFN-γ is a good candidate for the therapeutic treatment of MPNSTs in NF1.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neurofibromatosis 1Nerve Sheath NeoplasmsAntigens, DifferentiationHumansAnimalsMiceCell Line, TumorDown-RegulationFemaleGene Expression Regulation, NeoplasticMaleInterferon-gammaMAP Kinase Signaling Systemras ProteinsNeurofibromin 1Adult

Stichwörter der Autor:innen

interferon-gamma (IFN-γ)interferon-induced transmembrane protein 1 (IFITM1)malignant peripheral nerve sheet tumor (MPNST)neurofibromatosis type 1 (NF1)tumor progression

Substanzen

leu-13 antigenAntigens, DifferentiationInterferon-gammaras ProteinsNeurofibromin 1

Autor:innen und Institutionen

  • Department of Medical Genetics, Ajou University School of Medicine, Suwon 16499, Republic of Korea.
  • Jeju Bio Research Center, Jeju Research Institute, Korea Institute of Ocean Science & Technology (KIOST), Jeju-si 63349, Republic of Korea.
  • Jeonbuk Institute for Food-Bioindustry, Jeonju 54810, Republic of Korea.
  • Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon 16499, Republic of Korea.
  • Department of Pediatrics, Anam Hospital, Korea University College of Medicine, Seoul 02841, Republic of Korea.

ORCID-Profile: Gun-Hoo Park, Eunkuk Park, Seon-Yong Jeong

Förderung

  • Ministry of Health & Welfare, Republic of Korea
  • Korea University
  • Ministry of Health & Welfare, Republic of Korea

Zitieren

APA

Park, G. H., Park, E., Lee, S. J., Lim, K., Kim, J., Park, J. E., & Jeong, S. Y. (2024). Interferon-Induced Transmembrane Protein 1 (IFITM1) Is Downregulated in Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumors. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25179265

Vancouver

Park GH, Park E, Lee SJ, Lim K, Kim J, Park JE, et al. Interferon-Induced Transmembrane Protein 1 (IFITM1) Is Downregulated in Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumors. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25179265

BibTeX
@article{Park2024,
  author = {Park, Gun-Hoo and Park, Eunkuk and Lee, Su-Jin and Lim, Kyubin and Kim, Jeonghyun and Park, Jun Eun and Jeong, Seon-Yong},
  title = {Interferon-Induced Transmembrane Protein 1 (IFITM1) Is Downregulated in Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumors},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25179265}
}
Kostenlos starten →